<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00219804</url>
  </required_header>
  <id_info>
    <org_study_id>103,004</org_study_id>
    <nct_id>NCT00219804</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Tetrabenazine in Chorea</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled Study of Tetrabenazine for the Treatment of Huntington's Chorea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prestwick Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Prestwick Pharmaceuticals</source>
  <brief_summary>
    <textblock>
      The primary objective of this study was to establish the absolute reduction of chorea in
      participants with Huntington's disease(HD) treated with tetrabenazine or placebo
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <condition>Huntington's Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tetrabenazine or placebo</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  suffer from manifest HD as confirmed by genetic testing

          -  Meet chorea and total functional capacity scores on Unified Huntington's Disease
             Rating Scale

          -  Meet criteria on Hamilton Depression Rating Scale, Unified Parkinson's Disease Rating
             Scale dysphagia and dysarthria scale

          -  Independently ambulatory

        Exclusion Criteria

          -  previous treatment with tetrabenazine

          -  unstable or serious medical or psychiatric illness

          -  concomitant use identified drugs

          -  untreated depression

          -  lack of caregiver
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fred Marshall, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huntington's Study Group</affiliation>
  </overall_official>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>September 14, 2005</last_update_submitted>
  <last_update_submitted_qc>September 14, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Huntington Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetrabenazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

